Biliary Stents Market
By Type;
Metal, Polymer and PlasticBy Application;
Bilio-Pancreatic Leakages, Pancreatic Cancer, Benign Biliary Structures, Gallstones and OthersBy End Use;
Hospitals, Ambulatory Surgical Centers and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Biliary Stents Market Overview
Biliary Stents Market (USD Million)
Biliary Stents Market was valued at USD 540.40 million in the year 2024. The size of this market is expected to increase to USD 788.72 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.6%.
Biliary Stents Market
*Market size in USD million
CAGR 5.6 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 5.6 % |
| Market Size (2024) | USD 540.40 Million |
| Market Size (2031) | USD 788.72 Million |
| Market Concentration | Medium |
| Report Pages | 318 |
Major Players
- Blue Belt Technologies
- Boston Scientific Corporation
- Brainlab
- Claron Technology
- Fiagon
- GE Healthcare
- Karl Storz
- MAKO
- Medacta International
- Medtronic plc
- Micromar
- OrthAlign
- Scopis
- Stryker Corporation
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Biliary Stents Market
Fragmented - Highly competitive market without dominant players
Biliary Stents Market is expanding as endoscopy teams adopt innovative stent designs to ensure long-lasting bile duct clearance. With over 50% of specialized centers deploying self-expanding metal variants alongside plastics, targeted strategies are focusing on minimizing restenosis and repeat procedures. This strategic approach is maintaining steady growth in stent usage for biliary obstruction management.
Innovative Designs Improve Patient Outcomes
Featuring drug-eluting layers, biodegradable materials, and anti-migration features, more than 54% of new stents now reduce tissue growth and infection risk. These technological advancements elevate longevity, comfort, and clinical efficacy. Such innovation is enhancing acceptance among clinicians and optimizing therapeutic results.
Collaborative Models Expand Treatment Access
Around 48% of manufacturers are engaging in collaboration with endoscope suppliers, cancer centers, and imaging facilities. Through partnerships and merger efforts, they offer integrated stent kits and service bundles. This collaborative model boosts procedural efficiency and broadens stent adoption across hospital systems and outpatient centers.
Connected Technologies Define Future Outlook
With 56% of solutions integrating remote monitoring, imaging feedback, and data logging—the future outlook emphasizes smart stenting. Continued innovation in AI-based patency prediction and device-linked analytics is expected to drive growth by enabling proactive management and improving long-term outcomes.
Biliary Stents Market Key Takeaways
-
Rising prevalence of biliary obstructions and gallbladder disorders is driving demand for biliary stents that enable effective drainage and restore bile flow in patients with benign or malignant conditions.
-
Increasing adoption of minimally invasive endoscopic procedures is fueling the use of self-expandable metal and plastic stents, offering reduced recovery times and improved patient outcomes.
-
Technological advancements in stent design and coating materials such as anti-reflux and drug-eluting variants are enhancing biocompatibility and minimizing the risk of infection and blockage.
-
Growing incidence of pancreatic and bile duct cancers is expanding clinical applications for biliary stents as palliative solutions in complex gastrointestinal obstructions.
-
Rising demand for image-guided placement techniques such as ERCP and fluoroscopy is improving precision and procedural safety in biliary stenting interventions.
-
Increasing preference for metal stents over plastic types due to their longer patency and reduced replacement frequency is shaping product innovation trends in the market.
-
Collaborations between medical device companies and healthcare providers are fostering advancements in stent customization, expanding availability across both developed and emerging healthcare markets.
Biliary Stents Market Recent Developments
-
In February 2023, Olympus completed the acquisition of Taewoong Medical Co., Ltd., a Korean gastrointestinal stent manufacturer, to strengthen its Gastrointestinal EndoTherapy portfolio. The acquisition enhances Olympus’s capabilities by integrating advanced stent technologies and expanding its global reach in the endoscopic treatment market.
-
In November 2021, B. Braun entered into a strategic partnership with REVA Medical for the distribution of the Fantom Encore bioresorbable scaffold used in coronary interventions. This collaboration supports the advancement of next-generation cardiovascular solutions focused on improving patient outcomes.
Biliary Stents Market Segment Analysis
In this report, the Biliary Stents Market has been segmented by Type, Application, End Use and Geography. Market growth is strongly influenced by rising adoption of minimally invasive procedures, increasing prevalence of biliary obstructions, rising dependence on endoscopic interventions and growing demand for durable stent materials. Technological improvements and enhanced patient management workflows further support expansion.
Biliary Stents Market, Segmentation by Type
Segmentation by Type reflects the performance differences between stent materials and their varying clinical applications. Hospitals and surgical centers increasingly prefer stents that ensure long-term patency, support efficient drainage, reduce migration risk and improve procedural success. Advancements in stent design and surface engineering strengthen market adoption across patient groups.
MetalMetal stents are widely used for their high radial strength, excellent biocompatibility, improved patency rates and lower clogging probability. They remain preferred in complex obstructions where durability and long-term performance are required. Self-expanding properties further enhance their functional reliability.
PolymerPolymer stents support greater flexibility, ease of navigation, improved tissue compatibility and reduced procedural trauma. Their customizable designs and improved resistance to kinking contribute to expanded usage. Polymer-based improvements continue to enhance stability and drainage performance.
PlasticPlastic stents are cost-effective options offering reliable temporary drainage, easy replacement cycles, improved endoscopic maneuverability and low procedure complexity. They remain commonly used in short-term indications where routine follow-ups support timely replacement.
Biliary Stents Market, Segmentation by Application
The Application-based segmentation highlights growing usage of biliary stents across oncologic, structural and obstructive disorders. Increasing need for precision-guided drainage, effective stricture management, reduction in post-operative complications and improved patient recovery rates enhances clinical adoption across treatment pathways.
Bilio-Pancreatic LeakagesIn Bilio-Pancreatic Leakages, stents support controlled drainage, improved duct stabilization, reduced post-surgical complications and enhanced healing efficiency. Their ability to maintain luminal patency is crucial in preventing infectious or inflammatory complications.
Pancreatic CancerIn Pancreatic Cancer, stents are used to relieve malignant obstructions, enhance bile flow, reduce jaundice symptoms and support palliative care. Their role in reducing procedure frequency and improving patient comfort makes them essential to disease management.
Benign Biliary StructuresFor Benign Biliary Structures, stents facilitate duct dilation, reduce recurrence rates, improve bile passage and minimize procedure-associated trauma. Advanced stent designs enable better adaptability across varying anatomical complexities.
GallstonesIn Gallstones-related obstructions, stents ensure consistent drainage, reduce biliary colic episodes, lower infection risk and support duct patency until definitive treatment is performed. They also help stabilize acute presentations ahead of surgical intervention.
OthersOther applications include inflammatory and structural disorders requiring temporary drainage, improved ductal stabilization, enhanced flow restoration and reduced procedural risk. Broader clinical use continues to expand as minimally invasive approaches gain prominence.
Biliary Stents Market, Segmentation by End Use
Segmentation by End Use highlights growing usage of biliary stents in clinical facilities adopting advanced endoscopic procedures, prioritizing minimally invasive care, improving patient outcomes and enhancing workflow efficiency. Rising burden of biliary disorders strengthens demand across multiple care settings.
HospitalsHospitals represent the largest users due to high volumes of complex biliary cases, advanced endoscopy units, availability of specialist expertise and increased focus on precision-guided interventions. Greater access to multidisciplinary care accelerates adoption.
Ambulatory Surgical CentersAmbulatory Surgical Centers utilize biliary stents to support day-care procedures, reduce hospital stays, improve procedure efficiency and enhance treatment accessibility. Their flexible workflows make them suited for minimally invasive biliary interventions.
OthersOther facilities including specialty clinics adopt stents to improve outpatient management, support routine drainage needs, reduce procedure frequency and enhance clinical responsiveness. Growing availability of skilled endoscopists supports usage expansion.
Biliary Stents Market, Segmentation by Geography
In this report, the Biliary Stents Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
North America leads due to advanced endoscopic capabilities, strong infrastructure readiness, high burden of biliary malignancies and rapid adoption of metal stents. Strong procedural volumes and skilled professionals support consistent market expansion.
EuropeEurope shows strong usage driven by structured healthcare systems, wider access to minimally invasive therapies, adoption of innovative stent designs and strong focus on clinical outcomes. National screening initiatives further increase demand.
Asia PacificAsia Pacific experiences rising demand due to expanding cancer prevalence, improved hospital infrastructure, increasing procedure adoption and strong expansion of gastroenterology units. Growing investment in medical technology accelerates usage.
Middle East and AfricaMiddle East and Africa see growing adoption driven by improving treatment access, rising diagnostic capabilities, investment in advanced endoscopy and increasing clinical awareness. Urban-based healthcare systems exhibit faster uptake.
Latin AmericaLatin America expands due to increased endoscopic procedure rates, strengthening public-health programs, rising clinical specialization and improved care availability. Growing investment in minimally invasive surgery supports regional progress.
Biliary Stents Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Biliary Stents Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints, and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Aging Population
- Minimally Invasive Procedures
-
Rising Healthcare Expenditure - Rising healthcare expenditure is a significant driver shaping the dynamics of the biliary stents market. As economies grow and populations age, there is a natural increase in healthcare spending to address the growing burden of chronic diseases, including hepatobiliary disorders. This uptrend in healthcare expenditure translates into higher investment in medical infrastructure, advanced technologies, and innovative treatment modalities, including biliary stents, to improve patient outcomes and enhance quality of care.
Rising healthcare expenditure fosters greater accessibility to healthcare services, facilitating increased patient access to biliary stent procedures. With improved healthcare infrastructure and expanded insurance coverage, more patients can afford and access timely diagnosis and treatment for hepatobiliary conditions, driving the demand for biliary stents. This trend is particularly evident in developed economies where healthcare systems prioritize patient-centered care and technological innovation, leading to higher adoption rates of advanced medical devices like biliary stents.
The rising healthcare expenditure presents opportunities for market players to invest in research and development initiatives aimed at developing next-generation biliary stent technologies. With increased funding available for medical research and innovation, manufacturers can explore novel materials, design concepts, and therapeutic functionalities to enhance the efficacy, safety, and longevity of biliary stents. By leveraging the resources allocated to healthcare spending, stakeholders can drive continuous improvement and innovation in biliary stent technology, ultimately benefiting patients by offering more effective and personalized treatment options for hepatobiliary disorders.
Restraints
- Limited Reimbursement Policies
- Pricing Pressure
-
Lack of Skilled Healthcare Professionals - The shortage of skilled healthcare professionals poses a significant challenge to the biliary stents market, impacting various aspects of patient care, procedural outcomes, and market growth. Inadequate training and expertise among healthcare providers can lead to suboptimal patient management, procedural complications, and reduced patient satisfaction, hindering the effective utilization of biliary stent interventions in hepatobiliary disorders.
One of the primary concerns associated with the lack of skilled healthcare professionals is the potential for procedural errors and adverse events during biliary stent placement. Endoscopic procedures such as endoscopic retrograde cholangiopancreatography (ERCP) require specialized skills and proficiency in manipulating endoscopic instruments, navigating complex anatomical structures, and interpreting imaging findings. A shortage of adequately trained endoscopists and support staff can compromise the safety and efficacy of biliary stent procedures, leading to increased risks of complications and suboptimal clinical outcomes.
The lack of skilled healthcare professionals may contribute to disparities in access to biliary stent interventions, particularly in underserved or rural areas with limited healthcare resources. Patients in these regions may face challenges in accessing specialized care from experienced endoscopists or hepatobiliary surgeons, resulting in delayed diagnosis, substandard treatment, and poorer prognoses for biliary disorders. Addressing the shortage of skilled healthcare professionals requires concerted efforts from healthcare organizations, educational institutions, and policymakers to invest in training programs, continuing medical education, and workforce development initiatives tailored to the specific needs of hepatobiliary medicine. By enhancing the expertise and capabilities of healthcare professionals, stakeholders can improve the quality and accessibility of biliary stent interventions, ultimately benefiting patients and driving market growth in the biliary stents market.
Opportunities
- Personalized Medicine
- Strategic Collaborations and Partnerships
-
Focus on Patient Education and Awareness - A paramount aspect influencing the dynamics of the biliary stents market is the increasing focus on patient education and awareness. Empowering patients with knowledge about their conditions, treatment options, and the role of biliary stents in managing hepatobiliary disorders is essential for fostering informed decision-making, improving treatment adherence, and optimizing clinical outcomes.
Patient education plays a crucial role in enhancing understanding of hepatobiliary diseases, including their causes, symptoms, and potential complications. By providing clear and comprehensive information to patients and their caregivers, healthcare providers can promote early detection and prompt intervention for biliary conditions, leading to timely access to biliary stent procedures when indicated. Moreover, raising awareness about the importance of regular medical check-ups and screening tests can facilitate early diagnosis and intervention, preventing disease progression and reducing the need for more invasive treatments.
Educating patients about the benefits and limitations of biliary stents is essential for managing expectations and promoting realistic treatment goals. Patients need to understand the purpose of biliary stents, how they are inserted, and what to expect during and after the procedure, including potential risks and complications. By engaging patients in shared decision-making and involving them in treatment discussions, healthcare providers can enhance patient satisfaction, improve treatment adherence, and foster a sense of empowerment and autonomy in managing their health.
Increasing patient education and awareness can contribute to reducing stigma and misconceptions surrounding hepatobiliary disorders and biliary stent interventions. By dispelling myths and misinformation, healthcare providers can create a supportive environment that encourages open communication and proactive engagement in healthcare decision-making. Patient advocacy groups, educational resources, and online forums can also play a valuable role in disseminating accurate information and providing support to individuals affected by biliary conditions, further enhancing patient empowerment and engagement in their care journey.
Biliary Stents Market Competitive Landscape Analysis
Biliary Stents Market is becoming increasingly competitive as healthcare providers focus on advanced treatment solutions for biliary obstructions. Leading manufacturers are pursuing targeted strategies with strong emphasis on innovation and material enhancements. Around 40% of players are strengthening partnerships with hospitals, while nearly 30% explore merger activity to expand portfolios and drive sustainable growth.
Market Structure and Concentration
The sector displays moderate concentration, with top producers accounting for nearly 55% of revenues. Strategic merger and acquisitions have increased by more than 20%, leading to tighter market control. Around 25% of smaller companies rely on niche strategies with specialized stent designs. This structural alignment highlights increasing collaboration among suppliers and reinforces competitive growth.
Brand and Channel Strategies
Global manufacturers are aligning strategies across direct distribution and hospital procurement channels. More than 60% of sales come from established clinical partnerships, while franchise-style expansions contribute nearly 35% of coverage. Emphasis on collaboration with surgeons and procurement groups drives competitive advantage. These brand-driven initiatives support growth and reinforce expansion across emerging healthcare systems.
Innovation Drivers and Technological Advancements
Continuous innovation in self-expanding stents, bioabsorbable designs, and drug-coated technologies accounts for over 45% of investments. Automated production systems support consistency and safety, while digital tracking improves procedural outcomes. Technological advancements in minimally invasive techniques enhance adoption. These drivers accelerate growth, ensuring brands maintain relevance and strengthen their positioning through progressive strategies.
Regional Momentum and Expansion
North America holds about 35% market share, supported by clinical collaboration and high adoption rates. Asia-Pacific shows nearly 25% annual growth, fueled by healthcare infrastructure development and patient awareness. European expansion continues with more than 18% increase in strategic partnerships. Regional diversification ensures competitive momentum, with customized approaches aligning with procedural preferences and regulatory frameworks.
Future Outlook
The future landscape suggests strong growth prospects, with nearly 50% of companies planning major expansion initiatives. Cross-border collaboration is expected to redefine competitive advantages, while advanced stent technologies gain prominence. Strategic partnerships will accelerate adoption in new geographies. The market’s future outlook remains promising, driven by technological advancements and continued investment in minimally invasive healthcare solutions.
Key players in Biliary Stents Market include:
- Boston Scientific Corporation
- Cook Medical Inc.
- Medtronic plc
- Abbott Laboratories
- Olympus Corporation
- CONMED Corporation
- Becton, Dickinson and Company (BD)
- Merit Medical Systems, Inc.
- Micro-Tech Endoscopy USA
- Taewoong Medical Co., Ltd.
- ELLA-CS, s.r.o.
- ENDO-FLEX GmbH
- MI TECH Co., Ltd.
- Hobbs Medical, Inc.
- Teleflex Incorporated
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Biliary Stents Market Forces
- Drivers, Restraints and Opportunities
- Drivers
- Aging Population
- Minimally Invasive Procedures
- Rising Healthcare Expenditure
- Restraints
- Limited Reimbursement Policies
- Pricing Pressure
- Lack of Skilled Healthcare Professionals
- Opportunities
- Personalized Medicine
- Strategic Collaborations and Partnerships
- Focus on Patient Education and Awareness
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Biliary Stents Market, By Type, 2021 - 2031 (USD Million)
- Metal
- Polymer
- Plastic
- Biliary Stents Market, By Application, 2021 - 2031 (USD Million)
- Bilio-Pancreatic Leakages
- Pancreatic Cancer
- Benign Biliary Structures
- Gallstones
- Others
- Biliary Stents Market, By End Use, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Others
- Biliary Stents Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Biliary Stents Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Boston Scientific Corporation
- Cook Medical Inc.
- Medtronic plc
- Abbott Laboratories
- Olympus Corporation
- CONMED Corporation
- Becton, Dickinson and Company (BD)
- Merit Medical Systems, Inc.
- Micro-Tech Endoscopy USA
- Taewoong Medical Co., Ltd.
- ELLA-CS, s.r.o.
- ENDO-FLEX GmbH
- MI TECH Co., Ltd.
- Hobbs Medical, Inc.
- Teleflex Incorporated
- Company Profiles
- Analyst Views
- Future Outlook of the Market

